Fesoterodin-Mepha 4 mg
Fesoterodin-Mepha 4 mg is a medicine authorised by Swissmedic under authorisation number 68790. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 27 June 2022 and the authorisation is limited until 26 June 2027. ATC code G04BD11 places the medicine in the group Urologicals.
| Authorisation number | 68790 |
|---|---|
| Name | Fesoterodin-Mepha 4 mg |
| Full name | Fesoterodin-Mepha 4 mg, Retardtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | G04BD11 |
| First authorisation | 27 June 2022 |
| Authorisation validity | 26 June 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Fesoterodin-Mepha 4 mg, Retardtabletten | B | 27 June 2022 |
| 2 | Fesoterodin-Mepha 8 mg, Retardtabletten | B | 27 June 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 14 | Tablette(n) | G04BD11 | 05.02.0. | B |
| 2 | 84 | Tablette(n) | G04BD11 | 05.02.0. | B |
| 3 | 14 | Tablette(n) | G04BD11 | 05.02.0. | B |
| 4 | 84 | Tablette(n) | G04BD11 | 05.02.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Fesoterodin-Mepha 4 mg authorised in Switzerland?
Yes. Fesoterodin-Mepha 4 mg is authorised by Swissmedic under authorisation number 68790, data as of 01 September 2026. The authorisation is limited until 26 June 2027.
Which dispensing category does Fesoterodin-Mepha 4 mg have?
Fesoterodin-Mepha 4 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Fesoterodin-Mepha 4 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.